Funds with a thesis, stage focus, and check size comparable to The Leukemia Lymphoma Society S Therapy Acceleration Program.
The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. 48 funds share that profile, including Steven Leischner, Daniel Fabian and Jin Hing Chin.
The Leukemia Lymphoma Society S Therapy Acceleration Program alternatives · 2026 investor landscape
The Leukemia Lymphoma Society S Therapy Acceleration Program profile · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio companies · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory